Reduced recurrence rates with partial resection for stage III T1-2 colon cancer compared to hemicolectomy resection: a SEER database analysis
Authors:
Preprint
- 8 November 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Purpose The aim of our study was to compare the oncological survival outcomes between partial colectomy (PC) and hemicolectomy (HC) in patients diagnosed with stage III T1-2 colon cancer. Methods A total of 4,248 patients diagnosed with stage III T1-2 colon cancer, who underwent either hemicolectomy (n = 2,348) or partial colectomy (n = 1,900) between 2010 and 2019, were included in the Surveillance, Epidemiology, and End Results (SEER) database. We conducted a comparative analysis of overall survival (OS) and cancer-specific survival (CSS) between these two surgical groups. Additionally, we sought to determine the optimal thresholds for the number of harvested lymph nodes and tumor size. Predictive nomograms for patients with Stage III T1-2 colon cancer were constructed using independent risk factors identified CSS. Results The results revealed significant differences between the PC and HC groups in terms of age, gender, race, tumor site, histopathology, stage, pT, pN, scope of regional lymph nodes, postoperative chemotherapy, postoperative radiation, harvested lymph nodes, CEA pretreatment, marital status, and tumor size (all with P < 0.05). It was observed that hemicolectomy patients had slightly lower OS and CSS rates than patients who underwent partial colectomy (all with P < 0.001). Following propensity score matching (PSM), the OS and CSS rates in the two groups remained significantly different (P < 0.05). The survminer R package was employed to determine the optimal thresholds for harvested lymph node and tumor size counts in stage III T1-2 colon cancer patients, which were found to be 10 and 4.7 cm, respectively. Notably, CSS did not significantly differ between patients with ≥ 10 lymph nodes harvested and those with ≥ 12 lymph nodes harvested (P = 0.72). Univariate and multivariate Cox regression analyses, as well as survival analyses of stage III T1-2 colon cancer patients, demonstrated that patients receiving partial colectomy experienced a superior survival benefit compared to those undergoing hemicolectomy. Conclusions In the treatment of stage III T1-2 colon cancer patients, partial colectomy demonstrates significant oncological advantages over hemicolectomy. Harvested a minimum of 10 lymph nodes is more effective than the conventional threshold of 12 lymph nodes in distinguishing between patients with a favorable and unfavorable prognosis.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER databaseInternational Journal of Surgery, 2016
- Alterations of lymph nodes evaluation after colon cancer resection: patient and tumor heterogeneity should be taken into considerationOncotarget, 2016
- Assessment of lymph node involvement in colorectal cancerWorld Journal of Gastrointestinal Surgery, 2016
- Colorectal Cancer Resections in the Aging US PopulationJAMA Surgery, 2014
- Understanding Optimal Colonic Cancer Surgery: Comparison of Japanese D3 Resection and European Complete Mesocolic Excision With Central Vascular LigationJournal of Clinical Oncology, 2012
- Optimal margins and lymphadenectomy in colonic cancer surgeryBritish Journal of Surgery, 2011
- Value of Tumor Size as a Prognostic Variable in Colorectal CancerAmerican Journal of Clinical Oncology, 2011
- Laparoscopic resection of colon Cancer: Consensus of the European Association of Endoscopic Surgery (EAES)Surgical Endoscopy, 2004
- Survival After Curative Resection for Mucinous Adenocarcinoma of the ColorectumDiseases of the Colon & Rectum, 2003
- Surgery for colorectal cancer in elderly patients: a systematic reviewThe Lancet, 2000